Anwaar Saeed, Associate Professor and Chief of Gastrointestinal Medical Oncology at University of Pittsburgh, shared on X:
“Thrilled to present mature data from phase 2 CRC expansion cohort of ongoing DSP107 plus atezolizumab trial.
Appealing results in MSS CRC 3rd L and beyond suggesting synergy with this 1st in class trimeric fusion protein.”
Sorry: Anwaar Saeed/X